Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona
Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases (IRDs) and geographic atrophy secondary to macular degeneration, today announced presentations at the 24th Euretina congress taking place on September 19th-22nd in Barcelona, Spain. https://mma.prnewswire.com/media/1333752/Nanoscope_Therapeutics_Logo.jpg Details for the presentations are as follows: Title:Longitudinal AUC analysis of BCVA in patients treated with […]